previous compound ID: 2538 next compound
InChIKey: WYJAPUKIYAZSEM-MOPGFXCFSA-N
SMILES: CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=O)C2

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"D Rotin" "B Kus" "E Matthes" "GW Carlile" "J Goepp" "SD Macknight" "R Robert" "JW Hanrahan" "DY Thomas" "J Liao"

chemical graph of compound 2538





CID is 71203
synonyms found at PubChem are:
Vinburnine, (-)-Eburnamonine, Vincamone, eburnamonine, Eburnal, l-Eburnamonine, 4880-88-0, Eburnamonine (-), Eburnal ritardo, cis-Vincamone, Vinburnine [INN], Vincamona [Spanish], Vinburninum [INN-Latin], Vinburnina [INN-Spanish], UNII-G54D0HMY25, CH-846, (-)-Eburnamonina [Spanish], 3-alpha,16-alpha-Eburnamonine, Eburnamonine (-)-form, EINECS 225-490-5, CH 846, NSC 322920, 3alpha,16alpha-Eburnamonine, CHEBI:4740, G54D0HMY25, (3alpha,16alpha)-Eburnamenin-14(15H)-one, (3-alpha,16-alpha)-Eburnamin-14(15H)-one, Vinburnine (INN), NSC322920, (+/-)-Eburnamonine, DSSTox_CID_25119, DSSTox_RID_80685, DSSTox_GSID_45119, Vinburnina, Vinburninum, Vincanorine, Vincamona, DL-Eburnamonine, 16-Oxoeburnane, (-)-Eburnamonina, (+/-)-Vincamone, MLS000758467, Vinburnine, (+/-)-, Vinburnine base, Vinburnine/, NSC-322920, Eburnamonine (+/-)-form [MI], NCGC00014750-02, Cervoxan (TN), 2580-88-3, (-)-Vincamone, Prestwick_189, CAS-4880-88-0, eburnamonine, (3alpha,16alpha)-isomer, (-)-cis-Eburnamonine, Eburnamenin-14(15H)-one, (+/-)-, Spectrum_000379, AC1L2FQG, Prestwick0_000607, Prestwick1_000607, Prestwick2_000607, Prestwick3_000607, Spectrum2_001504, Spectrum3_001199, Spectrum4_000751, Spectrum5_000938, D0S4DT, AC1Q6PB6, NCIStruc1_000941, NCIStruc2_000870, Eburnamin-14(15H)-one, (3-alpha,16-alpha)-, BSPBio_000514, BSPBio_002877, GTPL345, KBioGR_001102, KBioSS_000859, MLS002153906, DivK1c_000411, SCHEMBL456385, SPBio_001547, SPBio_002733, BPBio1_000566, MEGxp0_001871, CHEMBL1892145, DTXSID6045119, ACon1_000004, HMS501E13, KBio1_000411, KBio2_000859, KBio2_003427, KBio2_005995, KBio3_002377, AOB5555, MolPort-001-742-589, NINDS_000411, HMS1569J16, HMS2096J16, HMS2233K13, HMS3713J16, ACT03251, BCP02373, HY-B1180, Tox21_110060, ABP000719, CCG-36740, NCI322920, ZINC19796061, AKOS015896486, Tox21_110060_1, CS-4789, MCULE-1030644698, MCULE-3457597200, IDI1_000411, NCGC00262533-02, NCGC00262533-03, AC-26459, CC-00046, NCI60_002800, SMR001233255, (3?,16?)-Eburnamenin-14(15H)-one, SBI-0051740.P002, LS-162178, ST24026040, W6490, C09149, D08676, C-18463, I06-1884, BRD-K40227168-001-03-8, BRD-K40227168-001-06-1, Eburnamin-14(15H)-one, (3-alpha,16-alpha)- (9CI), UNII-64UB2942IE component WYJAPUKIYAZSEM-MOPGFXCFSA-N, NCGC00262533-03_C19H22N2O_(3alpha,16alpha)-14,15-Dihydroeburnamenin-14-one, (31S,6aS)-6a-ethyl-31,4,5,6,6a,7-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridin-8(2H)-one, 13090-13-6, 412037-03-7, 6880-38-2